StockData

Cerenome vs INVO Fertility

CNSY and IVF side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CNSY and IVF compare

Cerenome and INVO Fertility are about the same size, with market caps of $7.2M and $6.5M.

INVO Fertility keeps more of each dollar of sales as profit, with a net margin of −92.3% compared with −859% at Cerenome.

Cerenome scores higher on the StockData Score (5 against 4 for INVO Fertility), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCNSYIVF
Size and price
Market cap$7.2M$6.5M
Share price$0.950$2.60
Change, 1 year−93.2%−97.1%
Change, 5 years−97.5%−100.0%
Beta (5Y)0.591.64
Employees2814
StockData Score
Total score5 (better)4
Valuation score11
Growth score11
Performance score01 (better)
Health score3 (better)1
Dividend score00
Valuation
P/S2.0×0.9× (better)
P/B–0.4×
FCF yield−398%–
Growth
Revenue growth (TTM)−32.9%–
Revenue growth, 5Y average–45.8%
Profitability
Operating margin−833%−78.7% (better)
Net margin−859%−92.3% (better)
FCF margin−813%–
Return on equity−1468%−149% (better)
Return on invested capital–−81.4%
Financial health
Debt / equity–0.10
Interest coverage−815.9×−5.2× (better)
Current ratio0.610.71 (better)
Altman Z-score−69.85−5.34 (better)
Piotroski F-score4 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions8.3%5.2%
Held by insiders4.2%5.2%
Insider net buying, 12 months$0 (better)−$6
Short interest, % of float11.6%0.32%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.